Prof Barry is a basic scientist with a long standing interest in the cell and molecular basis of immune tolerance, regulatory T cells and the molecular mechanisms that orchestrate their function. He is leading a program focussed on immunotherapies with projects focussed on reducing the costs of cell therapy manufacturing and on developing a novel CA-T cell targeting a broad range of cancers. He has experience from both academic and Biotech sector training, including working in the discovery research and functional genomics departments of Immunex and AMGEN. He currently heads the Molecular Immunology lab in the Robinson Research institute at the University of Adelaide based at the Women's and Childrens Hospital .